These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23888691)

  • 1. [Anti-inflammatory mechanism of qingfei xiaoyan wan studied with network pharmacology].
    Cheng BF; Hou YY; Jiang M; Zhao ZY; Dong LY; Bai G
    Yao Xue Xue Bao; 2013 May; 48(5):686-93. PubMed ID: 23888691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Searching for synergistic bronchodilators and novel therapeutic regimens for chronic lung diseases from a traditional Chinese medicine, Qingfei Xiaoyan Wan.
    Hou Y; Cheng B; Zhou M; Fang R; Jiang M; Hou W; Bai G
    PLoS One; 2014; 9(11):e113104. PubMed ID: 25397687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways.
    Hou Y; Nie Y; Cheng B; Tao J; Ma X; Jiang M; Gao J; Bai G
    Acta Pharm Sin B; 2016 May; 6(3):212-21. PubMed ID: 27175332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of transcriptomics and system pharmacology to reveal the therapeutic mechanism underlying Qingfei Xiaoyan Wan to treat allergic asthma.
    Hou JY; Wu JR; Xu D; Chen YB; Shang DD; Liu S; Fan GW; Cui YL
    J Ethnopharmacol; 2021 Oct; 278():114302. PubMed ID: 34090911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation.
    Zhao Z; Miao Y; Pan P; Cheng B; Bai G; Wu H
    BMC Complement Altern Med; 2013 Aug; 13():206. PubMed ID: 23919426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-bioactivity-based liquid chromatography-coupled quadrupole time-of-flight mass spectrometry for NF-κB inhibitors and β2AR agonists identification in Chinese Medicinal Preparation Qingfei Xiaoyan Wan.
    Cheng B; Hou Y; Wang L; Dong L; Peng J; Bai G
    Anal Bioanal Chem; 2012 Nov; 404(8):2445-52. PubMed ID: 22965529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory infection via the ERK pathway.
    Li Y; Chang N; Han Y; Zhou M; Gao J; Hou Y; Jiang M; Zhang T; Bai G
    Biomed Pharmacother; 2017 Oct; 94():758-766. PubMed ID: 28802227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated global chemomics and system biology approach to analyze the mechanisms of the traditional Chinese medicinal preparation Eriobotrya japonica - Fritillaria usuriensis dropping pills for pulmonary diseases.
    Tao J; Hou Y; Ma X; Liu D; Tong Y; Zhou H; Gao J; Bai G
    BMC Complement Altern Med; 2016 Jan; 16():4. PubMed ID: 26742634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice.
    Jiang YH; Yu JE; Guo AH; Li X; Lin Y; Jiang ZY; Xiao Z
    J Nat Med; 2016 Apr; 70(2):145-51. PubMed ID: 26590157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GC-MS based metabolomic profiling of lung tissue couple with network pharmacology revealed the possible protection mechanism of Pudilan Xiaoyan Oral Liquid in LPS-induced lung injury of mice.
    Tian G; Li C; Zhai Y; Xu J; Feng L; Yao W; Bao B; Zhang L; Ding A
    Biomed Pharmacother; 2020 Apr; 124():109833. PubMed ID: 31958766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Samsoeum water extract attenuates allergic airway inflammation via modulation of Th1/Th2 cytokines and decrease of iNOS expression in asthmatic mice.
    Jeon WY; Shin IS; Shin HK; Lee MY
    BMC Complement Altern Med; 2015 Mar; 15():47. PubMed ID: 25886760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of active components and mechanism of Pudilan Xiaoyan Oral Liquid based on network pharmacology].
    Dang Y; Meng-Hua J; Chen-Zi LI; Wei-Quan BU; E S; Liang F; Xiao-Bin J
    Zhongguo Zhong Yao Za Zhi; 2020 Sep; 45(18):4291-4298. PubMed ID: 33164355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network pharmacology-based strategy for predicting anti-inflammatory targets of ephedra in treating asthma.
    Huang XF; Cheng WB; Jiang Y; Liu Q; Liu XH; Xu WF; Huang HT
    Int Immunopharmacol; 2020 Jun; 83():106423. PubMed ID: 32279042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD.
    Zhao P; Li J; Li Y; Tian Y; Wang Y; Zheng C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2633-56. PubMed ID: 26674991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-allergic potential of Typhonium blumei: Inhibition of degranulation via suppression of PI3K/PLCγ2 phosphorylation and calcium influx.
    Korinek M; Chen KM; Jiang YH; El-Shazly M; Stocker J; Chou CK; Hwang TL; Wu YC; Chen BH; Chang FR
    Phytomedicine; 2016 Dec; 23(14):1706-1715. PubMed ID: 27912872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum pharmacochemistry of Qinbai Qingfei concentrated pellets based on UPLC-Q-TOF-MS].
    Liu Y; Wei WF; Huo JH; Wang WM
    Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(3):572-579. PubMed ID: 28952267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolol inhibits lipopolysaccharide-induced inflammatory response by interfering with TLR4 mediated NF-κB and MAPKs signaling pathways.
    Fu Y; Liu B; Zhang N; Liu Z; Liang D; Li F; Cao Y; Feng X; Zhang X; Yang Z
    J Ethnopharmacol; 2013 Jan; 145(1):193-9. PubMed ID: 23127653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF.
    Jiang M; Zhou M; Han Y; Xing L; Zhao H; Dong L; Bai G; Luo G
    J Ethnopharmacol; 2013 May; 147(2):426-33. PubMed ID: 23524166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fisetin inhibits the generation of inflammatory mediators in interleukin-1β-induced human lung epithelial cells by suppressing the NF-κB and ERK1/2 pathways.
    Peng HL; Huang WC; Cheng SC; Liou CJ
    Int Immunopharmacol; 2018 Jul; 60():202-210. PubMed ID: 29758489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-inflammatory effects of arctigenin, a lignan from Arctium lappa L., through inhibition on iNOS pathway.
    Zhao F; Wang L; Liu K
    J Ethnopharmacol; 2009 Apr; 122(3):457-62. PubMed ID: 19429312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.